SeaStar Medical Holding (ICU) Other Non-Current Assets (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Other Non-Current Assets came in at $499000.0 in Q1 2026, down 38.62% YoY from $813000.0 in Q1 2025, and down 13.67% on a QoQ basis from $578000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Other Non-Current Assets (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Other Non-Current Assets data on file, last reported at $499000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 38.62% year-over-year to $499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $499000.0 (down 38.62% YoY) and the FY2025 annual result came in at $578000.0, down 35.2% from the prior year.
- Other Non-Current Assets eased to $499000.0 in Q1 2026, from $578000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.5 million in Q4 2022 to a low of $499000.0 in Q1 2026.
- A 5-year average of $1.0 million and a median of $1.0 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 75850.0% — and 2026, when it slumped 38.62%.
- Tracing ICU's Other Non-Current Assets over 5 years: stood at $1.5 million in 2022, then decreased by 20.67% to $1.2 million in 2023, then dropped by 25.98% to $892000.0 in 2024, then slumped by 35.2% to $578000.0 in 2025, then retreated by 13.67% to $499000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $499000.0 (Q1 2026), $578000.0 (Q4 2025), and $656000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 421,000.00 |
| Mar 31, 2026 | 499,000.00 |
| Dec 31, 2025 | 578,000.00 |
| Sep 30, 2025 | 656,000.00 |
| Jun 30, 2025 | 736,000.00 |
| Mar 31, 2025 | 813,000.00 |
| Dec 31, 2024 | 892,000.00 |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 2,000.00 |